Literature DB >> 29154162

Epigenetic reprogramming in metabolic disorders: nutritional factors and beyond.

Zhiyong Cheng1, Louise Zheng2, Fabio A Almeida3.   

Abstract

Environmental factors (e.g., malnutrition and physical inactivity) contribute largely to metabolic disorders including obesity, type 2 diabetes, cardiometabolic disease and nonalcoholic fatty liver diseases. The abnormalities in metabolic activity and pathways have been increasingly associated with altered DNA methylation, histone modification and noncoding RNAs, whereas lifestyle interventions targeting diet and physical activity can reverse the epigenetic and metabolic changes. Here we review recent evidence primarily from human studies that links DNA methylation reprogramming to metabolic derangements or improvements, with a focus on cross-tissue (e.g., the liver, skeletal muscle, pancreas, adipose tissue and blood samples) epigenetic markers, mechanistic mediators of the epigenetic reprogramming, and the potential of using epigenetic traits to predict disease risk and intervention response. The challenges in epigenetic studies addressing the mechanisms of metabolic diseases and future directions are also discussed and prospected.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DNA methylation; Epigenetic marker; Intervention; Metabolic disorders; Reprogramming

Mesh:

Substances:

Year:  2017        PMID: 29154162      PMCID: PMC5866737          DOI: 10.1016/j.jnutbio.2017.10.004

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  158 in total

Review 1.  DNA methylation as a diagnostic and therapeutic target in the battle against Type 2 diabetes.

Authors:  Tina Rönn; Charlotte Ling
Journal:  Epigenomics       Date:  2015       Impact factor: 4.778

Review 2.  Mitochondrial fatty acid oxidation in obesity.

Authors:  Dolors Serra; Paula Mera; Maria Ida Malandrino; Joan Francesc Mir; Laura Herrero
Journal:  Antioxid Redox Signal       Date:  2012-10-05       Impact factor: 8.401

3.  Impact of polyunsaturated and saturated fat overfeeding on the DNA-methylation pattern in human adipose tissue: a randomized controlled trial.

Authors:  Alexander Perfilyev; Ingrid Dahlman; Linn Gillberg; Fredrik Rosqvist; David Iggman; Petr Volkov; Emma Nilsson; Ulf Risérus; Charlotte Ling
Journal:  Am J Clin Nutr       Date:  2017-03-08       Impact factor: 7.045

Review 4.  Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies.

Authors:  Nishanth E Sunny; Fernando Bril; Kenneth Cusi
Journal:  Trends Endocrinol Metab       Date:  2016-12-13       Impact factor: 12.015

Review 5.  Novel links between HIFs, type 2 diabetes, and metabolic syndrome.

Authors:  Christian M Girgis; Kim Cheng; Christopher H Scott; Jenny E Gunton
Journal:  Trends Endocrinol Metab       Date:  2012-07-04       Impact factor: 12.015

6.  Differential DNA methylation patterns between high and low responders to a weight loss intervention in overweight or obese adolescents: the EVASYON study.

Authors:  Adriana Moleres; Javier Campión; Fermín I Milagro; Ascensión Marcos; Cristina Campoy; Jesús M Garagorri; Sonia Gómez-Martínez; J Alfredo Martínez; M Cristina Azcona-Sanjulián; Amelia Martí
Journal:  FASEB J       Date:  2013-03-08       Impact factor: 5.191

7.  DNA 5-hydroxymethylation in human adipose tissue differs between subcutaneous and visceral adipose tissue depots.

Authors:  Kerstin Rohde; Maria Keller; Michael Stumvoll; Arne Dietrich; Matthias Blüher; Yvonne Böttcher
Journal:  Epigenomics       Date:  2015-09-29       Impact factor: 4.778

Review 8.  MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics.

Authors:  J A Deiuliis
Journal:  Int J Obes (Lond)       Date:  2015-08-27       Impact factor: 5.095

9.  DNA methylation and gene expression of HIF3A: cross-tissue validation and associations with BMI and insulin resistance.

Authors:  Ailsa Maria Main; Linn Gillberg; Anna Louisa Jacobsen; Emma Nilsson; Anette Prior Gjesing; Torben Hansen; Oluf Pedersen; Rasmus Ribel-Madsen; Allan Vaag
Journal:  Clin Epigenetics       Date:  2016-09-02       Impact factor: 6.551

Review 10.  Mitochondrial alteration in type 2 diabetes and obesity: an epigenetic link.

Authors:  Zhiyong Cheng; Fabio A Almeida
Journal:  Cell Cycle       Date:  2014-02-12       Impact factor: 4.534

View more
  25 in total

Review 1.  Exercise and the control of muscle mass in human.

Authors:  Marc Francaux; Louise Deldicque
Journal:  Pflugers Arch       Date:  2018-10-11       Impact factor: 3.657

Review 2.  Linking Lipid Metabolism to Chromatin Regulation in Aging.

Authors:  Katharina Papsdorf; Anne Brunet
Journal:  Trends Cell Biol       Date:  2018-10-10       Impact factor: 20.808

Review 3.  Anticancer Effects of Nutraceuticals in the Mediterranean Diet: An Epigenetic Diet Model.

Authors:  Rosa Divella; Antonella Daniele; Eufemia Savino; Angelo Paradiso
Journal:  Cancer Genomics Proteomics       Date:  2020 Jul-Aug       Impact factor: 4.069

Review 4.  DNA methylation markers in obesity, metabolic syndrome, and weight loss.

Authors:  Mirian Samblas; Fermín I Milagro; Alfredo Martínez
Journal:  Epigenetics       Date:  2019-03-27       Impact factor: 4.528

5.  Evaluation of the promoter methylation status of hypoxia factor 3A and interleukin-6 genes and expression levels of mir-130b and mir-146b in childhood obesity.

Authors:  Esra Tekcan; Nurten Kara; Hasan Murat Aydın; Ümmet Abur; Mohsen Abbaszadeh
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-09       Impact factor: 1.712

6.  Association of Cardiovascular Health Through Young Adulthood With Genome-Wide DNA Methylation Patterns in Midlife: The CARDIA Study.

Authors:  Yinan Zheng; Brian T Joyce; Shih-Jen Hwang; Jiantao Ma; Lei Liu; Norrina B Allen; Amy E Krefman; Jun Wang; Tao Gao; Drew R Nannini; Haixiang Zhang; David R Jacobs; Myron D Gross; Myriam Fornage; Cora E Lewis; Pamela J Schreiner; Stephen Sidney; Dongquan Chen; Philip Greenland; Daniel Levy; Lifang Hou; Donald M Lloyd-Jones
Journal:  Circulation       Date:  2022-06-02       Impact factor: 39.918

Review 7.  Approaching precision medicine by tailoring the microbiota.

Authors:  Gaeun Ryu; Hyojin Kim; Ara Koh
Journal:  Mamm Genome       Date:  2021-03-01       Impact factor: 2.957

Review 8.  Synergizing Mouse and Human Studies to Understand the Heterogeneity of Obesity.

Authors:  Penny Gordon-Larsen; John E French; Naima Moustaid-Moussa; Venkata S Voruganti; Elizabeth J Mayer-Davis; Christopher A Bizon; Zhiyong Cheng; Delisha A Stewart; John W Easterbrook; Saame Raza Shaikh
Journal:  Adv Nutr       Date:  2021-10-01       Impact factor: 11.567

9.  Global epigenetic alterations of mesenchymal stem cells in obesity: the role of vitamin C reprogramming.

Authors:  Mohsen Afarideh; Roman Thaler; Farzaneh Khani; Hui Tang; Kyra L Jordan; Sabena M Conley; Ishran M Saadiq; Yasin Obeidat; Aditya S Pawar; Alfonso Eirin; Xiang-Yang Zhu; Amir Lerman; Andre J van Wijnen; Lilach O Lerman
Journal:  Epigenetics       Date:  2020-09-20       Impact factor: 4.528

10.  No detectable differential microRNA expression between non-atherosclerotic arteries of type 2 diabetic patients (treated or untreated with metformin) and non-diabetic patients.

Authors:  Lasse Bach Steffensen; Søren Feddersen; Simone Rørdam Preil; Lars Melholt Rasmussen
Journal:  Cardiovasc Diabetol       Date:  2018-05-17       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.